✓
Open
11 Nov 2025
✓
Close
13 Nov 2025
3
Allotment
—
✓
Listing
Tue, Nov 18, 2025
Price Band
₹108 to ₹114
Issue Size
61,78,800 shares (agg. up to ₹70 Cr)
Lot Size
1,200 Shares
Listing Date
Tue, Nov 18, 2025
Latest GMP
₹0
Est. Gain
0%
✦ AI Insight
GMP Trend
18-11-2025₹0Est. ₹114+0%
17-11-2025₹0Est. ₹114+0%
16-11-2025₹0Est. ₹114+0%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 1.48x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Total Income | 84.04 | 267.17 | 162.83 | 137.40 |
| Profit After Tax | 4.10 | 12.94 | 5.22 | 3.75 |
| EBITDA | 8.04 | 24.64 | 13.36 | 8.91 |
| NET Worth | 53.50 | 49.42 | 24.66 | 19.44 |
| Reserves and Surplus | 35.73 | 31.66 | 23.41 | 18.19 |
| Total Borrowing | 57.72 | 58.11 | 54.63 | 24.37 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Advance Agrolife Ltd. | Mainboard | ₹192.85 Cr | ₹100 | 17.55 | ₹108.30 | +8.30% | ₹115.67 (+2.94%) |
| Indogulf Cropsciences Ltd. | Mainboard | ₹200.00 Cr | ₹111 | 19.18 | ₹110.35 | -0.59% | ₹72.02 (-1.17%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of Equipment for existing Formulation plant | 3.75 |
| 2 | Funding capital expenditure towards setting up of a new technical manufacturing plant | 29.42 |
| 3 | Construction of Warehouse Building and Purchase of Machinery | 2.53 |
| 4 | Funding working capital requirements of the Company | 18.00 |
| 5 | General Corporate Purposes | 8.26 |
| 6 | Issue Expenses | 2.54 |
| Total | 64.50 |
About Mahamaya Lifesciences IPO
Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management and to help the farming community for more productivity. The company specializes in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs). The company imports carefully researched molecules, registers them with the Central Insecticides Board, and markets them as technical and value-added formulations for domestic manufacturers and multinational corporations (MNCs). The company has invested in global product registrations, with active markets in countries like the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations. Product Portfolio: Bulk Formulations Sales: Acetamiprid, SP Buprofezin, SC Emamectin benzoate, SG Imidacloprid, SC Paraquat Dichloride. Technical Sales: Acetamiprid Technical 99% Min, Atrazine Technical 95% Min, Imidacloprid Technical 95% Min, Emamectin Benzoate Technical 95% Min. Branded Sales (Major own branded products): MAYAM
Contact Details
Mahamaya Lifesciences Ltd. AddressUnit No: DPT 033, Ground FloorPlot No: 79 80, DLF Prime TowerBlock, Okhla, Phase-1Delhi, New Delhi, 110020+91-1146561474cs@mahamayalifesciences.comVisit Website